Overcoming the blood–brain barrier (BBB) remains a significant challenge with regard to
drug delivery to the brain. By incorporating targeting ligands, and by carefully adjusting …

Hypothesis: The use of tumor cell membrane-camouflaged nanoparticles, specifically the
multifunctional biomimetic core–shell nanosystem MPCONPs, can enhance the targeting …

Core-shell nanocarriers (Fe 3 O 4-MSN-TESPA-PEG/DOX) with a core-shell structure were
created as possible materials for controlled drug retention and release. With a notable …

GLP‐1R agonist peptides play a prominent role in the treatment of type 2 diabetes.
However, these peptides often suffer from short plasma half‐life, rapid clearance, and low in …

Targeting the alpha-v beta-3 integrin receptor holds promise for active targeting in cancer
therapy and imaging diagnostics. Cyclic (arginine-glycine-aspartate-phenylalanine-lysine) …

In the last few decades, carbon nanotubes (CNTs) have been the focus of significant
research in the field of medicine owing to their unique characteristics and wide range of …